What is C R Bard's stock symbol?
C R Bard trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCR."
How often does C R Bard pay dividends? What is the dividend yield for C R Bard?
C R Bard declared a quarterly dividend on Wednesday, December 14th. Shareholders of record on Monday, January 23rd will be given a dividend of $0.26 per share on Friday, February 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date of this dividend is Thursday, January 19th.
Where is C R Bard's stock going? Where will C R Bard's stock price be in 2017?
15 brokerages have issued 12 month price objectives for C R Bard's shares. Their predictions range from $205.00 to $265.00. On average, they anticipate C R Bard's share price to reach $242.38 in the next twelve months.
When will C R Bard announce their earnings?
C R Bard is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.
What are analysts saying about C R Bard stock?
Here are some recent quotes from research analysts about C R Bard stock:
According to Zacks Investment Research, "C. R. Bard reported stellar fourth-quarter 2016 results, crushing the Zacks Consensus Estimate on both counts, courtesy of growth from each of its four businesses both domestically and internationally. Over the past one year, C. R. Bard has outperformed the broader industry trends with respect to price performances. The company has gained prominence in the market with an expanding product portfolio and continuing regulatory approvals. The growing adoption of Lutonix DCB is expected to drive top-line growth in the coming quarters. Meanwhile, solid performance by the company’s vascular product, oncology, surgical specialties and urology platforms are encouraging. Also, a rising estimate revision trend indicates analysts are becoming more bullish on the stock. Finally, C. R. Bard’s full year 2017 earnings guidance, which reflects a solid year-over increase between 11% and 14%, impressed us." (1/31/2017)
Needham & Company LLC analysts commented, "BCR’s 4Q16 revenue and EPS beat consensus and management provided initial 2017 revenue guidance that was in line with consensus and EPS guidance that was above consensus. Organic revenue growth improved to 6.9% in 4Q16 from 6.4% in 3Q16. Although BCR’s gross margin declined slightly, its operating margin improved by 150 bps Y/Y due to significant SG&A leverage." (1/27/2017)
Who owns C R Bard stock?
C R Bard's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (5.04%), Putnam Investments LLC (1.63%), FMR LLC (1.29%), Renaissance Technologies LLC (0.69%), AQR Capital Management LLC (0.68%) and Frontier Capital Management Co. LLC (0.65%). Company insiders that own C R Bard stock include Anthony Welters, Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Patricia G Christian, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White.
Who sold C R Bard stock? Who is selling C R Bard stock?
C R Bard's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, AQR Capital Management LLC, I.G. Investment Management LTD., Tudor Investment Corp Et Al, Prudential PLC, Numeric Investors LLC and Bessemer Group Inc.. Company insiders that have sold C R Bard stock in the last year include Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White.
Who bought C R Bard stock? Who is buying C R Bard stock?
C R Bard's stock was bought by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., State Street Corp, Asset Management One Co. Ltd., Russell Investments Group Ltd., Marshall Wace LLP, Federated Investors Inc. PA, Broadfin Capital LLC and Janus Capital Management LLC.
How do I buy C R Bard stock?
Shares of C R Bard can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of C R Bard stock cost?
One share of C R Bard stock can currently be purchased for approximately $245.18.